Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BREAST-AB Trial: Prophylactic Antibiotics for Breast Implants
NCT04731025Phase 3Active, not recruiting
- Start
- Jan 2021
- Primary completion
- Sep 2026
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
A Phase 3 trial of gentamicin, vancomycin, cefazolin in peri-implantitis. Started Jan 2021; status: active, not recruiting.
02
Drugs
gentamicinvancomycincefazolin
03
Conditions
peri-implantitis
Beyond the preview
Go deeper on NCT04731025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04731025.